We are live on ! Find out more
Eventide Asset Management

Eventide Asset Management Portfolio holdings

AUM $7.48B Turnover 27.68%
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+18.78%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$5.71B
AUM Growth
+$688M
Cap. Flow
-$39.8M
Cap. Flow %
-0.7%
Top 10 Hldgs %
24.42%
Holding
257
New
40
Increased
127
Reduced
58
Closed
20
Avg Time Held
1.7 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$26.6M
2
CHWY icon
Chewy
CHWY
+$26M
3
VRSK icon
Verisk Analytics
VRSK
+$25.3M
4
FTDR icon
Frontdoor
FTDR
+$24.3M
5
LRCX icon
Lam Research
LRCX
+$20.6M

Sector Composition

Rank Sector Weight
1 Healthcare 37.06%
2 Technology 18.81%
3 Industrials 18.23%
4 Consumer Discretionary 7.44%
5 Utilities 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WCN icon
26
Waste Connections
WCN
$42.2B
$57.7M 1.01%
309,168
+332
+0.1% +$64K
2016 Q4
34 quarters
MTD icon
27
Mettler-Toledo International
MTD
$32.5B
$57M 1%
48,553
+4,549
+10% +$5.08M
2018 Q2
28 quarters
DHI icon
28
D.R. Horton
DHI
$39B
$57M 1%
441,990
+2,135
+0.5% +$263K
2019 Q4
22 quarters
AXON icon
29
Axon Enterprise
AXON
$31.7B
$55.7M 0.98%
67,321
+32
+0% +$21.8K
2025 Q1
1 quarter
RBA icon
30
RB Global
RBA
$15.6B
$55.7M 0.98%
524,132
+417
+0.1% +$42.7K
2024 Q4
2 quarters
ASML icon
31
ASML
ASML
$631B
$54.1M 0.95%
67,461
-3,089
-4% -$2.22M
2013 Q4
46 quarters
VRSK icon
32
Verisk Analytics
VRSK
$24.8B
$53.3M 0.93%
171,132
+83,419
+95% +$25.3M
2020 Q1
21 quarters
ETR icon
33
Entergy
ETR
$50.2B
$49.7M 0.87%
593,097
-25,994
-4% -$2.15M
2024 Q4
2 quarters
NDAQ icon
34
Nasdaq
NDAQ
$52.5B
$48.7M 0.85%
544,901
+73,372
+16% +$5.86M
2024 Q3
3 quarters
NTNX icon
35
Nutanix
NTNX
$18.1B
$48.4M 0.85%
632,735
+2,420
+0.4% +$174K
2024 Q1
5 quarters
ORLY icon
36
O'Reilly Automotive
ORLY
$72.2B
$47.6M 0.83%
528,336
+2,691
+0.5% +$245K
2022 Q4
10 quarters
HUBS icon
37
HubSpot
HUBS
$11.5B
$47.4M 0.83%
85,186
+389
+0.5% +$228K
2017 Q2
32 quarters
DDOG icon
38
Datadog
DDOG
$88.7B
$46.9M 0.82%
349,150
-7,050
-2% -$781K
2019 Q3
23 quarters
EVH icon
39
Evolent Health
EVH
$517M
$46M 0.81%
4,086,852
-1,990,339
-33% -$18.3M
2022 Q2
12 quarters
CHWY icon
40
Chewy
CHWY
$8.43B
$45.4M 0.8%
1,065,572
+651,697
+157% +$26M
2025 Q1
1 quarter
MNDY icon
41
monday.com
MNDY
$3.82B
$45.1M 0.79%
143,331
+1,081
+0.8% +$301K
2023 Q3
7 quarters
VMC icon
42
Vulcan Materials
VMC
$33.4B
$43.8M 0.77%
167,982
+80
+0% +$20.6K
2025 Q1
1 quarter
GLBE icon
43
Global E Online
GLBE
$6.52B
$41.1M 0.72%
1,224,532
-299,217
-20% -$10.1M
2021 Q3
15 quarters
ALNY icon
44
Alnylam Pharmaceuticals
ALNY
$31B
$41.1M 0.72%
125,902
-40,548
-24% -$11.2M
2023 Q4
6 quarters
STE icon
45
Steris
STE
$21.7B
$40.5M 0.71%
168,608
+3,009
+2% +$701K
2020 Q2
20 quarters
PNR icon
46
Pentair
PNR
$8.53B
$39.5M 0.69%
384,462
+80,967
+27% +$7.56M
2020 Q4
18 quarters
EGP icon
47
EastGroup Properties
EGP
$10.6B
$39.4M 0.69%
235,867
+1,167
+0.5% +$194K
2021 Q4
14 quarters
NVDA icon
48
NVIDIA
NVDA
$5.17T
$39.2M 0.69%
247,611
+44,292
+22% +$5.57M
2022 Q4
10 quarters
NVT icon
49
nVent Electric
NVT
$23B
$38.9M 0.68%
531,223
+9,643
+2% +$592K
2021 Q2
16 quarters
TTD icon
50
Trade Desk
TTD
$5.78B
$37.5M 0.66%
521,903
+136,253
+35% +$8.7M
2017 Q2
32 quarters

Similar funds

Eventide Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Eventide Asset Management held 257 positions worth $5.71B, up 14% from $5.02B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2025 filing shows 40 new, 127 increased, 58 reduced and 20 closed positions. Its largest new stake was Frontdoor: 483,677 shares worth $28.5M. The largest sale was Celldex Therapeutics, an estimated $46.7M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2025 buy was Frontdoor: 483,677 shares worth $28.5M.
  • Eventide Asset Management added most to EQT Corp in Q2 2025, an estimated $26.6M increase.
  • Eventide Asset Management's biggest Q2 2025 reduction was Celldex Therapeutics, cutting an estimated $46.7M.
  • Eventide Asset Management fully exited Krystal Biotech in Q2 2025, selling an estimated $17.3M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $5.71B portfolio in Q2 2025.
  • Eventide Asset Management opened 40 new positions and closed 20 in Q2 2025.
  • Eventide Asset Management's portfolio value rose 14% quarter-over-quarter to $5.71B.

Based on Eventide Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.